Show
Sort by
-
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis
-
One-year safety and efficacy of ustekinumab and results of dose adjustment after switching from inadequate methotrexate treatment: the TRANSIT randomized trial in moderate-to-severe plaque psoriasis
-
Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT)
-
Juvenile psoriasis and its clinical management: a European expert group consensus
-
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus